XML 281 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning balance at Mar. 31, 2021 $ 182,545 $ 2,176 $ 180,524 $ (155)
Balance, shares at Mar. 31, 2021   30,576    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (22,431)   (22,431)  
Unrealized loss on marketable securities, net of income tax expense (4)     (4)
Foreign currency translation adjustment, including income tax expense (benefit) (368)     (368)
Stock-based compensation expense 6,262 $ 6,262    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   646    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (2,441) $ (2,441)    
Common stock issued under employee stock purchase plan, shares   46    
Common stock issued under employee stock purchase plan 486 $ 486    
Balance, shares at Mar. 31, 2022   31,268    
Ending balance at Mar. 31, 2022 164,049 $ 6,483 158,093 (527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (105,399)   (105,399)  
Unrealized loss on marketable securities, net of income tax expense 0     0
Foreign currency translation adjustment, including income tax expense (benefit) (951)     (951)
Stock-based compensation expense 3,885 $ 3,885    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   458    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (497) $ (497)    
Common stock issued under employee stock purchase plan, shares   119    
Common stock issued under employee stock purchase plan 213 $ 213    
Balance, shares at Mar. 31, 2023   31,845    
Ending balance at Mar. 31, 2023 $ 61,300 $ 10,084 $ 52,694 $ (1,478)